Details for New Drug Application (NDA): 203917
✉ Email this page to a colleague
The generic ingredient in ACETAZOLAMIDE is acetazolamide sodium. There are ten drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the acetazolamide sodium profile page.
Summary for 203917
Tradename: | ACETAZOLAMIDE |
Applicant: | Rising |
Ingredient: | acetazolamide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 203917
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 500MG | ||||
Approval Date: | Jun 18, 2019 | TE: | RLD: | No |
Complete Access Available with Subscription